Peptides in Oncology III: Somatostatin and LH-RH Analogues: 153 (Recent Results in Cancer Research, 153) - Image 1

£72.07

Springer Peptides in Oncology III: Somatostatin and LH-RH Analogues: 153 (Recent Results in Cancer Research, 153)

Name: Peptides in Oncology III: Somatostatin and LH-RH Analogues: 153 (Recent Results in Cancer Research, 153)
Brand: Springer
Price: 36.0 GBP
Availability: InStock

Living with Cancer & Other Illnesses

Price History & Forecast

Last 32 days • 32 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 32 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £36 (31 days, 96.9%)

Price range: £36 - £72

Price levels: 2 different prices over 32 days

Description

Interference with protein-mediated intra- and intercellular pathways has become a major goal of preclinical and clinical research. A ,rapidly increasing numBer of peptides are known to be responsible for endo-, para-and autocrine sig- nal transduction. These peptides and their receptors have been studied with regard to their cell growth stimulatory ac- tion and their impact on differentiation. In parallel, peptide antagonists are being investigated in terms of their potential role in preclinical and clinical application. Thus, biotherapy might improve the clinical outcome of patients with tumors that respond to the respective hormonal manipulation. Among the numerous peptides of interest somatostatin (somatotropin release inhibitory factor) and the luteinizing hormone releasing hormone (LH-RH) have been the topic of intensive research during recent years. In this third vol- ume of peptides in oncology, experts in the field exten- sively review and update the mechanisms of action of so- matostatin and LH -RH -analogues in oncology. Somatostatin and its various short-and long-acting ana- logues have the unique feature of suppressing and inhibit- ing a wide range of cellular processes including cell prolif- eration. Receptors for these peptides which belong to the family of neuropeptides or neurotransmitters, are widely distributed, a feature which is not in keeping with the gen- eral view of a growth hormone regulatory system. LH -RH analogues play an established role in curative (adjuvant) and palliative treatment of hormone sensitive tumors.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3540644296
Category: Books > Subjects > Biography > Social & Health Issues > Living with Cancer & Other Illnesses
Domain: Amazon UK
Release Date: 12 November 1999
Listed Since: 16 December 2006

Barcode

No barcode data available

Springer Peptides in Oncology III: Somatostatin and LH-RH Analogues: 153 (Recent Results in Cancer Research, 153)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - Peptides and Non Peptides of Oncologic Relevance

Small Molecules for Cancer Treatment

SOMATOSTATIN SYNTH.MECHANISMS: Synthesis, Mechanisms-of-Action & Physiological Effects (Endorinology Research and Clinical Developments)

Regulatory Peptides and Cognate Receptors: 26 (Results and Problems in Cell Differentiation, 26)

Regulatory Peptides and Cognate Receptors: 26 (Results and Problems in Cell Differentiation, 26)

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Growth Hormone Secretagogues in Clinical Practice

Pharmaceutical Perspectives of Cancer Therapeutics

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Springer - Drug Resistance in Leukemia and Lymphoma III

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Resistance to Aromatase Inhibitors in Breast Cancer: 8 (Resistance to Targeted Anti-Cancer Therapeutics, 8)

Springer - From Molecular to Modular Tumor Therapy Book

Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)

Hematopoietic Growth Factors in Oncology: 157 (Cancer Treatment and Research, 157)

Growth Hormone II: Basic and Clinical Aspects (Serono Symposia USA)

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Endocrine Neoplasia: 153 (Cancer Treatment and Research, 153)